T
Ted R. Mikuls
H指数:79
被引数:2.5万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk
超越尿酸酶疗法预防抗药抗体形成:改善痛风发作风险的DMARDs机制作用
Biodrugs
IF6.9
Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis
虚弱可预测类风湿关节炎退伍军人中新发骨质疏松性骨折
Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study
目标治疗降尿酸疗法:来自STOP痛风研究的经验教训
Inferring rheumatoid arthritis disease activity status from the electronic health records across health systems
从跨医疗系统的电子健康记录中推断类风湿关节炎疾病活动状态
Arthritis & Rheumatology
IF10.9
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset
老年类风湿关节炎(RA)患者接受生物制剂或靶向合成DMARDs治疗时的严重感染风险:发病年龄的作用
Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk
联合三种外周血生物标志物对类风湿关节炎相关间质性肺疾病风险进行分层
Burden of Disease and Drug Response for Patients With Rheumatoid Arthritis by Shared Epitope and Anticitrullinated Protein Antibody Status
类风湿关节炎患者的疾病负担和药物反应与共享表位和抗瓜氨酸化蛋白抗体状态的关系
High Disease Activity is Associated with Incident Osteoporotic Fractures Among Veterans with Rheumatoid Arthritis
高疾病活动度与类风湿关节炎退伍军人中新发骨质疏松性骨折相关
Joint Bone Spine
IF4.3
Malondialdehyde-acetaldehyde modified macromolecules and resulting autoantibodies in rheumatoid arthritis pathogenesis: a Systematic Literature Review
丙二醛-乙醛修饰的大分子及其在类风湿关节炎发病机制中产生的自身抗体:系统文献综述
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)
美国接受免疫检查点抑制剂(ICIs)治疗的类风湿关节炎退伍军人死亡率
Financial Distress and its Determinants in Rheumatoid Arthritis
类风湿关节炎中的财务困境及其决定因素
Performance of an Idiopathic Pulmonary Fibrosis Derived Multibiomarker Panel for Rheumatoid Arthritis-Associated Interstitial Lung Disease
特发性肺纤维化衍生多生物标志物组合在类风湿关节炎相关间质性肺疾病中的表现
Arthritis & Rheumatology
IF10.9
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
羟氯喹在类风湿关节炎风险个体中的2期临床试验
Arthritis & Rheumatology
IF10.9

